Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis
Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hinde...
Saved in:
Published in: | Drug design, development and therapy Vol. 16; pp. 2365 - 2382 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Macclesfield
Dove Medical Press Limited
01-01-2022
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA |
---|---|
AbstractList | BackgroundAs the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and MethodsLUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. ResultsIn this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. ConclusionThe results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein-protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA Fei-Ran Yang,1,* Si-Yi Li,1,* Xi-Wen Hu,1 Xiu-Rong Li,2 Hui-Jie Li2 1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 2Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hui-Jie Li; Xiu-Rong Li, Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jingshi Road, Jinan, Shandong, 250014, People’s Republic of China, Email 2008lihuijie@163.com; szylxr2012@126.comBackground: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin.Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein–protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells.Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes.Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment.Graphical Abstract: Keywords: lung adenocarcinoma, curcumin, antitumor effect, bioinformatics analysis, TCGA Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the drug has hindered the widespread use of the natural product. In the present study, we used comprehensive bioinformatics analysis and in vitro experiments to explore the anti-tumor mechanism of curcumin. Materials and Methods: LUAD mRNA expression data were obtained from TCGA database and differentially expressed genes (DEGs) were identified using R software. Functional enrichment analysis was conducted to further clarify its biological properties and hub genes were identified by a protein–protein interaction (PPI) network analysis. Survival analysis and molecular docking were used to analyze the effectiveness of the hub genes. By an in vitro study, we evaluated whether curcumin could influence the proliferation, migration, and invasion activities of LUAD cells. Results: In this study, 1783 DEGs from LUAD tissue samples compared to normal samples were evaluated. Functional enrichment analysis and the PPI network revealed the characteristics of the DEGs. We performed a topological analysis and identified 10 hub genes. Of these, six genes (INS, GCG, SST, F2, AHSG, and NPY) were identified as potentially effective biomarkers of LUAD. The molecular docking results indicated that curcumin targets in regulating lung cancer may be INS and GCG. We found that curcumin significantly inhibited the proliferation, migration, and invasion of LUAD cells and significantly decreased the expression of the INS and GCG genes. Conclusion: The results of this study suggest that the therapeutic effects of curcumin on LUAD may be achieved through the intervention of INS and GCG, which may act as potential biomarkers for LUAD prevention and treatment. Graphical Abstract: |
Audience | Academic |
Author | Hu, Xi-Wen Li, Xiu-Rong Li, Si-Yi Yang, Fei-Ran Li, Hui-Jie |
Author_xml | – sequence: 1 fullname: Yang, Fei-Ran – sequence: 2 fullname: Li, Si-Yi – sequence: 3 fullname: Hu, Xi-Wen – sequence: 4 fullname: Li, Xiu-Rong – sequence: 5 fullname: Li, Hui-Jie |
BookMark | eNptkk9v0zAYhyM0xLbCjQ8QCQlxoMWO_yUXpK4dUKkSB7az5TivG1eJXexkUr89Dq1gRSiHxM7zPol_-t1mV847yLK3GC0KTMWn9Xr9sPhBBKYFepHdYCzEvCxLfPXs-Tq7jXGPECe8QK-ya8IqjESJb7LDpgE3WHO0bpcPLeTLtBrG3of83hjQQ8y9yVdj0GNvXe5dvh0TuUxTXqugrfO9yh_jNL7y_SFACy7aJ8jvrLfO-NCrweqYvKo7RhtfZy-N6iK8Od9n2eOX-4fVt_n2-9fNarmda8bIMBekqGvcINQIQiulKQONNDBEac0FUcxg3ugEGFoUFSoFaFUQpEvKjGYcyCzbnLyNV3t5CLZX4Si9svL3hg87qUL6sw4krRky0BhOMaNMM5XCLE2tsQKkRUOT6_PJdRjrHhqdEguqu5BevnG2lTv_JCtSVLwskuDDWRD8zxHiIHsbNXSdcuDHKAteCVRxnk42y979g-79GFJ4iRKIYF5VmPyldiodYMo5fVdPUrlMTUgeJCZq8R8qXQ30VqcaGZv2LwbePxtoQXVDG303Dta7eAl-PIE6-BgDmD9hYCSnWsqplvJcS_ILUe_UwA |
CitedBy_id | crossref_primary_10_1016_j_jep_2023_116565 crossref_primary_10_1111_1759_7714_15121 crossref_primary_10_1021_acsabm_3c01145 crossref_primary_10_1007_s11101_023_09894_9 |
Cites_doi | 10.1007/s40618-016-0508-7 10.1007/978-1-59745-177-2_19 10.1158/0008-5472.CAN-14-2317 10.1016/j.cell.2018.02.052 10.1038/nature11412 10.1007/s10822-007-9114-2 10.1007/s11626-014-9779-5 10.1371/journal.pone.0171628 10.1016/j.nutres.2014.09.001 10.5604/01.3001.0010.5273 10.1158/0008-5472.CAN-12-3385 10.1016/j.jcte.2018.12.005 10.3322/caac.21235 10.3389/fendo.2019.00481 10.1056/NEJMra1703413 10.3390/ijms13033959 10.1200/JCO.2007.13.9030 10.3389/fonc.2014.00204 10.1016/j.jff.2015.01.005 10.1016/j.ejca.2018.11.002 10.5114/wo.2014.47136 10.1530/ERC-11-0374 10.1093/bioinformatics/bts251 10.1002/ptr.6422 10.1371/journal.pone.0083922 10.1021/jm020406h 10.1371/journal.pone.0099317 10.1111/cpr.12575 10.1155/2013/239354 10.1210/me.2010-0120 10.1007/s00018-008-8281-1 10.1016/j.lfs.2016.02.022 10.1016/j.biosystems.2014.11.005 10.3390/ijms20184606 10.1080/10408398.2018.1552244 10.3892/ijo.2015.2865 10.1007/s10549-016-4013-7 10.1111/apt.12092 10.1016/0002-9610(85)90406-4 10.1002/JLB.3MR0320-444R 10.1093/nar/gks1094 10.2174/1389450119666181022153016 10.1159/000440941 10.1158/0008-5472.CAN-07-6734 10.1002/jat.2814 10.1016/j.gene.2021.145666 10.1002/ptr.6620 10.1002/ptr.6037 10.1016/j.phymed.2019.152893 10.1039/D1FO02002A 10.1126/science.1141478 10.1007/s10552-015-0613-5 10.3892/ijo.2012.1480 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.0.CO;2-C 10.1155/2012/789174 10.1158/1078-0432.CCR-07-4495 10.1080/22221751.2020.1719902 10.2147/JEP.S70568 10.2174/1381612823666170622105123 10.1016/j.jtho.2017.08.008 10.1186/1471-2105-4-2 10.1038/nrendo.2015.51 10.18632/oncotarget.24367 10.1038/nrc3775 10.1016/j.jnutbio.2013.11.001 10.3892/or.2015.4258 10.1016/j.bmc.2017.01.043 10.1023/A:1011980313237 10.1016/j.phrs.2017.03.001 10.1038/nm.3391 10.3322/caac.21551 10.3892/ol.2015.3324 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Dove Medical Press Limited 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Yang et al. 2022 Yang et al. |
Copyright_xml | – notice: COPYRIGHT 2022 Dove Medical Press Limited – notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Yang et al. 2022 Yang et al. |
DBID | AAYXX CITATION 3V. 7QO 7RV 7XB 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ P64 PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/DDDT.S371420 |
DatabaseName | CrossRef ProQuest Central (Corporate) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) ProQuest research library Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts ProQuest Central Korea ProQuest Research Library ProQuest Central Basic ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Yang et al |
EISSN | 1177-8881 |
EndPage | 2382 |
ExternalDocumentID | oai_doaj_org_article_4b50fedf641545c5a3718fbc1ae0c7d4 A714673073 10_2147_DDDT_S371420 |
GeographicLocations | China United States--US |
GeographicLocations_xml | – name: China – name: United States--US |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29G 2WC 53G 5GY 5VS 7RV 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ACIWK ACPRK ADBBV ADRAZ AENEX AFKRA AFRAH AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD EMOBN F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW INH INR IPNFZ ITC KQ8 M2O M48 MK0 M~E NAPCQ O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RPM SV3 TDBHL TR2 UKHRP VDV 3V. 7QO 7XB 8FD 8FK COVID FR3 MBDVC P64 PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c553t-732bb1d00d7349ac45ec0ce5044b673a5f16dc1d0f4229087eca230c845fc56e3 |
IEDL.DBID | RPM |
ISSN | 1177-8881 |
IngestDate | Tue Oct 22 15:15:13 EDT 2024 Tue Sep 17 21:24:08 EDT 2024 Fri Aug 16 22:14:39 EDT 2024 Thu Oct 10 22:02:13 EDT 2024 Tue Nov 19 21:12:01 EST 2024 Tue Nov 12 23:01:12 EST 2024 Tue Aug 20 22:12:03 EDT 2024 Fri Aug 23 01:22:12 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c553t-732bb1d00d7349ac45ec0ce5044b673a5f16dc1d0f4229087eca230c845fc56e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work |
ORCID | 0000-0001-8483-9337 0000-0001-8560-4951 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329682/ |
PMID | 35910781 |
PQID | 2703169913 |
PQPubID | 2046454 |
PageCount | 18 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4b50fedf641545c5a3718fbc1ae0c7d4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9329682 proquest_miscellaneous_2697096667 proquest_journals_2703169913 gale_infotracmisc_A714673073 gale_infotracacademiconefile_A714673073 gale_healthsolutions_A714673073 crossref_primary_10_2147_DDDT_S371420 |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Macclesfield |
PublicationPlace_xml | – name: Macclesfield |
PublicationTitle | Drug design, development and therapy |
PublicationYear | 2022 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
References | Gunter (ref73) 2015; 75 Chen (ref50) 2008; 68 Parekh (ref62) 2015; 26 Liu (ref22) 2018; 173 Jin (ref40) 2015; 34 Wang (ref58) 2019; 52 Jiao (ref24) 2012; 28 Mantzorou (ref18) 2018; 32 Ye (ref42) 2012; 13 Hsin (ref29) 2013; 8 Janssen (ref63) 2013; 37 Morris (ref53) 2008; 443 Siegel (ref1) 2019; 69 Wan (ref6) 2013; 19 Engelman (ref43) 2007; 316 Korpanty (ref7) 2014; 4 Vallianou (ref38) 2015; 35 Zhang (ref39) 2013; 33 Hernandez (ref74) 2014; 9 Jiang (ref17) 2017; 119 Um (ref37) 2014; 34 Adeva-Andany (ref68) 2019; 15 Rodríguez Castaño (ref49) 2019; 20 Yagi (ref67) 2018; 9 Lánczky (ref28) 2016; 160 Jain (ref32) 2003; 46 DeSantis (ref4) 2014; 64 Pignon (ref3) 2008; 26 David (ref33) 2017; 12 Kumar (ref20) 2016; 148 Arcidiacono (ref60) 2012; 2012 Reuveni (ref57) 2013; 73 Panda (ref19) 2017; 9 Weichhaus (ref71) 2012; 41 Vivacqua (ref69) 2017; 23 Moyer (ref66) 1985; 150 Vigneri (ref70) 2016; 39 Sahebkar (ref36) 2015; 18 Chen (ref2) 2014; 14 Prasad (ref21) 2008; 14 Ichiki (ref14) 2000; 18 Nouri-Vaskeh (ref16) 2020; 34 Shiozaki (ref48) 1996; 77 Zhang (ref52) 2017; 12 Sarkar (ref59) 2019; 10 Saikia (ref54) 2019; 20 Cohen (ref72) 2012; 19 Koboldt (ref35) 2012; 490 Lu (ref41) 2014; 50 Yang (ref31) 2021; 788 Wattanathamsan (ref9) 2019; 33 Jain (ref30) 2007; 21 Chan (ref51) 2020; 9 Argilés (ref61) 2001; 18 Reck (ref5) 2017; 377 Campbell (ref64) 2015; 11 Hancock (ref65) 2010; 24 Tunc (ref13) 2017; 25 Matyszewski (ref55) 2015; 10 Matyszewski (ref56) 2015; 46 van Roy (ref47) 2008; 65 Kang (ref34) 2016; 61 Hu (ref12) 2017; 16 Tomczak (ref23) 2015; 19 Prelaj (ref8) 2019; 106 Liang (ref44) 2021; 12 Deng (ref11) 2020; 108 Ahsan (ref45) 2013; 2013 Franceschini (ref25) 2013; 41 Lin (ref10) 2019; 58 Patel (ref15) 2020; 60 Jiang (ref46) 2014; 25 Tang (ref27) 2015; 127 Bader (ref26) 2003; 4 |
References_xml | – volume: 35 start-page: 645 year: 2015 ident: ref38 publication-title: Anticancer Res contributor: fullname: Vallianou – volume: 39 start-page: 1365 year: 2016 ident: ref70 publication-title: J Endocrinol Invest doi: 10.1007/s40618-016-0508-7 contributor: fullname: Vigneri – volume: 443 start-page: 365 year: 2008 ident: ref53 publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-177-2_19 contributor: fullname: Morris – volume: 75 start-page: 270 year: 2015 ident: ref73 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-2317 contributor: fullname: Gunter – volume: 173 start-page: 400 year: 2018 ident: ref22 publication-title: Cell doi: 10.1016/j.cell.2018.02.052 contributor: fullname: Liu – volume: 490 start-page: 61 year: 2012 ident: ref35 publication-title: Nature doi: 10.1038/nature11412 contributor: fullname: Koboldt – volume: 21 start-page: 281 year: 2007 ident: ref30 publication-title: J Comput Aided Mol Des doi: 10.1007/s10822-007-9114-2 contributor: fullname: Jain – volume: 50 start-page: 840 year: 2014 ident: ref41 publication-title: In Vitro Cell Dev Biol Anim doi: 10.1007/s11626-014-9779-5 contributor: fullname: Lu – volume: 12 start-page: e0171628 year: 2017 ident: ref52 publication-title: PLoS One doi: 10.1371/journal.pone.0171628 contributor: fullname: Zhang – volume: 34 start-page: 886 year: 2014 ident: ref37 publication-title: Nutr Res doi: 10.1016/j.nutres.2014.09.001 contributor: fullname: Um – volume: 16 start-page: 835 year: 2017 ident: ref12 publication-title: Ann Hepatol doi: 10.5604/01.3001.0010.5273 contributor: fullname: Hu – volume: 73 start-page: 4383 year: 2013 ident: ref57 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-3385 contributor: fullname: Reuveni – volume: 15 start-page: 45 year: 2019 ident: ref68 publication-title: J Clin Transl Endocrinol doi: 10.1016/j.jcte.2018.12.005 contributor: fullname: Adeva-Andany – volume: 64 start-page: 252 year: 2014 ident: ref4 publication-title: CA Cancer J Clin doi: 10.3322/caac.21235 contributor: fullname: DeSantis – volume: 10 start-page: 481 year: 2019 ident: ref59 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2019.00481 contributor: fullname: Sarkar – volume: 377 start-page: 849 year: 2017 ident: ref5 publication-title: N Engl J Med doi: 10.1056/NEJMra1703413 contributor: fullname: Reck – volume: 13 start-page: 3959 year: 2012 ident: ref42 publication-title: Int J Mol Sci doi: 10.3390/ijms13033959 contributor: fullname: Ye – volume: 26 start-page: 3552 year: 2008 ident: ref3 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.13.9030 contributor: fullname: Pignon – volume: 4 start-page: 204 year: 2014 ident: ref7 publication-title: Front Oncol doi: 10.3389/fonc.2014.00204 contributor: fullname: Korpanty – volume: 18 start-page: 898 year: 2015 ident: ref36 publication-title: J Funct Foods doi: 10.1016/j.jff.2015.01.005 contributor: fullname: Sahebkar – volume: 106 start-page: 144 year: 2019 ident: ref8 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2018.11.002 contributor: fullname: Prelaj – volume: 19 start-page: A68 year: 2015 ident: ref23 publication-title: Contemp Oncol doi: 10.5114/wo.2014.47136 contributor: fullname: Tomczak – volume: 19 start-page: F27 year: 2012 ident: ref72 publication-title: Endocr Relat Cancer doi: 10.1530/ERC-11-0374 contributor: fullname: Cohen – volume: 28 start-page: 1805 year: 2012 ident: ref24 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts251 contributor: fullname: Jiao – volume: 18 start-page: 683 year: 2001 ident: ref61 publication-title: Int J Oncol contributor: fullname: Argilés – volume: 33 start-page: 2531 year: 2019 ident: ref9 publication-title: Phytother Res doi: 10.1002/ptr.6422 contributor: fullname: Wattanathamsan – volume: 8 start-page: e83922 year: 2013 ident: ref29 publication-title: PLoS One doi: 10.1371/journal.pone.0083922 contributor: fullname: Hsin – volume: 46 start-page: 499 year: 2003 ident: ref32 publication-title: J Med Chem doi: 10.1021/jm020406h contributor: fullname: Jain – volume: 9 start-page: e99317 year: 2014 ident: ref74 publication-title: PLoS One doi: 10.1371/journal.pone.0099317 contributor: fullname: Hernandez – volume: 52 start-page: e12575 year: 2019 ident: ref58 publication-title: Cell Prolif doi: 10.1111/cpr.12575 contributor: fullname: Wang – volume: 2013 start-page: 239354 year: 2013 ident: ref45 publication-title: Biomed Res Int doi: 10.1155/2013/239354 contributor: fullname: Ahsan – volume: 24 start-page: 1605 year: 2010 ident: ref65 publication-title: Mol Endocrinol doi: 10.1210/me.2010-0120 contributor: fullname: Hancock – volume: 65 start-page: 3756 year: 2008 ident: ref47 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-008-8281-1 contributor: fullname: van Roy – volume: 148 start-page: 313 year: 2016 ident: ref20 publication-title: Life Sci doi: 10.1016/j.lfs.2016.02.022 contributor: fullname: Kumar – volume: 127 start-page: 67 year: 2015 ident: ref27 publication-title: Bio Syst doi: 10.1016/j.biosystems.2014.11.005 contributor: fullname: Tang – volume: 20 start-page: 4606 year: 2019 ident: ref49 publication-title: Int J Mol Sci doi: 10.3390/ijms20184606 contributor: fullname: Rodríguez Castaño – volume: 60 start-page: 887 year: 2020 ident: ref15 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2018.1552244 contributor: fullname: Patel – volume: 46 start-page: 1435 year: 2015 ident: ref56 publication-title: Int J Oncol doi: 10.3892/ijo.2015.2865 contributor: fullname: Matyszewski – volume: 160 start-page: 439 year: 2016 ident: ref28 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-016-4013-7 contributor: fullname: Lánczky – volume: 37 start-page: 18 year: 2013 ident: ref63 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12092 contributor: fullname: Janssen – volume: 150 start-page: 676 year: 1985 ident: ref66 publication-title: Am J Surg doi: 10.1016/0002-9610(85)90406-4 contributor: fullname: Moyer – volume: 108 start-page: 493 year: 2020 ident: ref11 publication-title: J Leukoc Biol doi: 10.1002/JLB.3MR0320-444R contributor: fullname: Deng – volume: 41 start-page: D808 year: 2013 ident: ref25 publication-title: Nucleic Acids Res doi: 10.1093/nar/gks1094 contributor: fullname: Franceschini – volume: 20 start-page: 501 year: 2019 ident: ref54 publication-title: Curr Drug Targets doi: 10.2174/1389450119666181022153016 contributor: fullname: Saikia – volume: 61 start-page: 41 year: 2016 ident: ref34 publication-title: Chemotherapy doi: 10.1159/000440941 contributor: fullname: Kang – volume: 68 start-page: 7428 year: 2008 ident: ref50 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6734 contributor: fullname: Chen – volume: 33 start-page: 1468 year: 2013 ident: ref39 publication-title: J Appl Toxicol doi: 10.1002/jat.2814 contributor: fullname: Zhang – volume: 788 start-page: 145666 year: 2021 ident: ref31 publication-title: Gene doi: 10.1016/j.gene.2021.145666 contributor: fullname: Yang – volume: 34 start-page: 1446 year: 2020 ident: ref16 publication-title: Phytother Res doi: 10.1002/ptr.6620 contributor: fullname: Nouri-Vaskeh – volume: 32 start-page: 957 year: 2018 ident: ref18 publication-title: Phytother Res doi: 10.1002/ptr.6037 contributor: fullname: Mantzorou – volume: 58 start-page: 152893 year: 2019 ident: ref10 publication-title: Phytomedicine doi: 10.1016/j.phymed.2019.152893 contributor: fullname: Lin – volume: 12 start-page: 10667 year: 2021 ident: ref44 publication-title: Food Funct doi: 10.1039/D1FO02002A contributor: fullname: Liang – volume: 316 start-page: 1039 year: 2007 ident: ref43 publication-title: Science doi: 10.1126/science.1141478 contributor: fullname: Engelman – volume: 26 start-page: 1189 year: 2015 ident: ref62 publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0613-5 contributor: fullname: Parekh – volume: 41 start-page: 745 year: 2012 ident: ref71 publication-title: Int J Oncol doi: 10.3892/ijo.2012.1480 contributor: fullname: Weichhaus – volume: 77 start-page: 1605 year: 1996 ident: ref48 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.0.CO;2-C contributor: fullname: Shiozaki – volume: 2012 start-page: 789174 year: 2012 ident: ref60 publication-title: Exp Diabetes Res doi: 10.1155/2012/789174 contributor: fullname: Arcidiacono – volume: 14 start-page: 3327 year: 2008 ident: ref21 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-4495 contributor: fullname: Prasad – volume: 9 start-page: 221 year: 2020 ident: ref51 publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1719902 contributor: fullname: Chan – volume: 9 start-page: 31 year: 2017 ident: ref19 publication-title: J Exp Pharmacol doi: 10.2147/JEP.S70568 contributor: fullname: Panda – volume: 23 start-page: 3658 year: 2017 ident: ref69 publication-title: Curr Pharm Des doi: 10.2174/1381612823666170622105123 contributor: fullname: Vivacqua – volume: 12 start-page: 1636 year: 2017 ident: ref33 publication-title: J Thoracic Oncol doi: 10.1016/j.jtho.2017.08.008 contributor: fullname: David – volume: 4 start-page: 2 year: 2003 ident: ref26 publication-title: BMC Bioinform doi: 10.1186/1471-2105-4-2 contributor: fullname: Bader – volume: 11 start-page: 329 year: 2015 ident: ref64 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2015.51 contributor: fullname: Campbell – volume: 9 start-page: 10650 year: 2018 ident: ref67 publication-title: Oncotarget doi: 10.18632/oncotarget.24367 contributor: fullname: Yagi – volume: 14 start-page: 535 year: 2014 ident: ref2 publication-title: Nat Rev Cancer doi: 10.1038/nrc3775 contributor: fullname: Chen – volume: 25 start-page: 241 year: 2014 ident: ref46 publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2013.11.001 contributor: fullname: Jiang – volume: 34 start-page: 2782 year: 2015 ident: ref40 publication-title: Oncol Rep doi: 10.3892/or.2015.4258 contributor: fullname: Jin – volume: 25 start-page: 1717 year: 2017 ident: ref13 publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2017.01.043 contributor: fullname: Tunc – volume: 18 start-page: 539 year: 2000 ident: ref14 publication-title: Clin Exp Metastasis doi: 10.1023/A:1011980313237 contributor: fullname: Ichiki – volume: 119 start-page: 373 year: 2017 ident: ref17 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.03.001 contributor: fullname: Jiang – volume: 19 start-page: 1450 year: 2013 ident: ref6 publication-title: Nat Med doi: 10.1038/nm.3391 contributor: fullname: Wan – volume: 69 start-page: 7 year: 2019 ident: ref1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 contributor: fullname: Siegel – volume: 10 start-page: 589 year: 2015 ident: ref55 publication-title: Oncol Lett doi: 10.3892/ol.2015.3324 contributor: fullname: Matyszewski |
SSID | ssj0063620 |
Score | 2.3266532 |
Snippet | Background: As the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have... Previous studies have demonstrated that curcumin has great potential as a therapeutic agent, but the lack of understanding of the functional mechanism of the... BackgroundAs the main component of turmeric (Curcuma longa L.), curcumin is widely used in the treatment of various diseases. Previous studies have... Fei-Ran Yang,1,* Si-Yi Li,1,* Xi-Wen Hu,1 Xiu-Rong Li,2 Hui-Jie Li2 1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine,... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 2365 |
SubjectTerms | Adenocarcinoma Anticancer properties Antitumor activity antitumor effect Apoptosis B cells Bioinformatics bioinformatics analysis Biological properties Biomarkers Cancer therapies Care and treatment Cell cycle Cell growth Cell proliferation Chemical compounds Computational biology Computer graphics Curcumin Gene expression Gene set enrichment analysis Genes Health aspects Immunotherapy Kinases Ligands lung adenocarcinoma Lung cancer Molecular docking Natural products Network analysis Neuropeptide Y Original Research Pharmacology Protein-protein interactions Proteins RNA Software Survival analysis tcga Technology application Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07b9RAEF5BKhoEAcRBCIsEoYmJvd6Xy0suUQqEIuWQ6Fb7snLF2ZEvLvLvmfH6LjEUNLTesWzvzH4zY818Q8hn5mrObFVkRfQ64875rFIiZLX1igmttK-wG_nyWv34pRfnSJOzG_WFNWGJHjht3Al3Iq9jqCVHZ--FLQFNa-cLG3OvQmICzeU2mUoYLAGW8zRWBTBY6yKVvONMnpPFYrH8do1EdTjj-5EzGjj7_0bmP6slH7mfixfk-Rg30nl635fkSWz2ydFVIp6-P6bLhz6qzTE9olcPlNT3r8ht6scdepoohHx0jt25_brtaKIv3tC2pmd95_v1qqFtQ78DCNA53AW-rvOrpl1bOpQXUESQLt6kwnd6umpH7lV8Mt1ynLwmPy_Ol2eX2ThrIfNClHeZKplzRcjzoEpeWc9F9LmPIufcSVVaURcyeBAA1bIq1yp6C9mL11zUXshYviF7TdvEt4QGG2ReKctcySHZLJwPLDAIJDWzLFg5I1-2m25uE6WGgVQElWNQOWZUzoycokZ2MkiEPVwA8zCjeZh_mceMfER9mtRVujvOZq7QRSDAzcjXQQI3C_Tr7diXAB-D1FgTyYOJJBxEP13e2owZgWBjGM4HkBCEw_Kn3TLeicVtTWx7kJGVgkxSSjUjamJrk2-frjSrm4EMHOLvSmr27n9s1nvyjGF3x_CH6YDs3XV9_ECebkJ_OByv3wkyLBo priority: 102 providerName: Directory of Open Access Journals |
Title | Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis |
URI | https://www.proquest.com/docview/2703169913 https://search.proquest.com/docview/2697096667 https://pubmed.ncbi.nlm.nih.gov/PMC9329682 https://doaj.org/article/4b50fedf641545c5a3718fbc1ae0c7d4 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfYTlwQn6IwhpFgXJY2cfyRHLt20w6AKq1I3CL72WGVaFKly2H_Pc9O0hG4cY2flcTP78t6v58J-chMyZnOkyhxkEXcGIhyJWxUalBMZCqD3KORr2_Utx_Z8tLT5IgBCxOa9sFsptWv7bTa3Ibeyt0WZkOf2Gz1dYE5Ry4zNjsiR5gbDiV6534leuS463D3V_DMlsvlenrjeemYv_UtFRgfVZaMwlBg6__XJ__dJ_lH4Ll6Sp70GSOdd1_2jDxy1XNytuoop-_P6foBQbU_p2d09UBGff-C7DokbkAzUUz26Nzjcttt3dCOuHhP65Iu2gba7aaidUW_oPnTOc7CKNfApqq3mobGAup9R-Nuu5Z3erGpe9ZV_2Y6sJu8JN-vLteL66i_ZSECIdK7SKXMmMTGsVUpzzVw4SAGJ2LOjVSpFmUiLaAAKpXlcaYcaKxbIOOiBCFd-oocV3XlXhNqtZVxrjQzKccyMzFgmWWYQmZMM6vlhHwaFr3YdWQaBRYhXk-F11PR62lCLrxGDjKeAjs8qJufRb8RCm5EXDpbSu6zQBAa52algUS7GJTlE_Le67Po8KQHQy7mygcH79om5HOQ8IuF-gXdIxLwZzwp1kjyZCSJJgjj4WHPFL0L2BfM3wwgMf3G4Q-HYT_Tt7VVrm5RRuYKa0gp1YSo0V4b_ft4BK0i0ID3VvDmv2e-JY-ZB3OEA6UTcnzXtO4dOdrb9jQcTZwGw_oNKWAq8A |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53801,53803 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RcoAL5amGFrpIUC51Yq_3YR_TpFUQaRWpQeK22pdpJGJHTn3ov2fWjxTDrVfPrPyY2XlY832L0GeiM0pUGgWRM0lAtTZBKpgNMmUEYYlITOrRyLMbcf0zmV54mhzWYWHqoX2jV8P893qYr27r2crN2oy6ObHR4moCNUfKEzLaQ09hv4ZR16Q3AZhDTA6bGXd_CM9oOp0uhzeemY74c99iBhlSJFEvEdV8_f9H5X8nJf9KPZcHj3zol-hFW2vicSN-hZ64_DU6XTRk1fdnePmAvdqe4VO8eKCxvn-DNg2Gt8ZBYSgT8dgjeqt1UeKG8niLiwxPqtJU61WOixzPIXDgMayC_FiaVV6sFa5HErCPOqW7bYbl8fmqaPla_Z1xx4vyFv24vFhOZkF7PkNgGIvvAhETrSMbhlbENFWGMmdC41hIqeYiViyLuDWgAO5A0jARzijoeExCWWYYd_E7tJ8XuTtE2CrLw1QoomMKDWqkjSWWQPGZEEWs4gP0pTOW3DQ0HBLaF29f6e0rW_sO0Lm35E7Hk2fXF4ryl2ytIalmYeZsxqmvHw1TsDbJtImUC42wdIBOvB_IBom6CwFyLHxa8UFxgL7WGv5jgV8Y1WIZ4GU8nVZP87inCZvX9MWdr8k2eGwl8WcKcCjcQfxpJ_Yr_UBc7ooKdHgqoPvkXAyQ6Plo7937EnDNmkC8dcX3j155gp7NlldzOf92_f0IPSceElL_ljpG-3dl5T6gva2tPtbb8g9kND-L |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYkBAvfCO6DWYkGC9LmzixnTx27aohxlRpReLNss8Oq0STKl0e9t9zTtKOwBu85u6UjzvfR3T3O0I-MJMnTGdREDlIg8QYCDLJbZBrkIynMoXMTyNfXMur7-n03MPk7FZ9NU37YJbD4udqWCxvmt7K9QpG2z6x0fzrBHOOTKRstLb5aI88xDMbxttCvXXCAv1y2Pa5-0U8o-l0uhhee3Q65ne_xRyjpEyjXjBqMPv_9sx_dkv-Fn5mT__jwZ-RJ13OSccty3PywBUvyMm8Ba2-O6WL-xmszSk9ofN7OOu7l2TdzvI281AU00U69pO99aqsaAt9vKFlTid1BfVqWdCyoJfoQOgYpTBOVrAsypWmTWsC9d6ncjdt0zw9W5Ydbqu_M93io7wi32bni8lF0O1pCIDz-DaQMTMmsmFoZZxkGhLuIATHwyQxQsaa55GwgAxoFiwLU-lAY-UDacJz4MLFr8l-URbuDaFWWxFmUjMTJ1ioRgYsswyT0JRpZrUYkI9bhal1C8ehsIzxOlZex6rT8YCceW3ueDyIdnOhrH6oTiMqMTzMnc1F4vNI4Bpl09xApF0I0iYDcuxtQbUTqTtXoMbShxfvHAfkU8PhPxbaBuhupgFfxsNq9TiPepx4iKFP3tqb6pzIRjG_W0BgAo_k9zuyl_SNcYUra-QRmcQqVAg5ILJnp71371PQPBsg8c4cD_5Z8pg8mk9n6vLz1ZdD8pj5yZDm79QR2b-taveW7G1s_a45mb8ARXpCCw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identifying+the+Antitumor+Effects+of+Curcumin+on+Lung+Adenocarcinoma+Using+Comprehensive+Bioinformatics+Analysis&rft.jtitle=Drug+design%2C+development+and+therapy&rft.au=Yang%2C+FR&rft.au=Li%2C+SY&rft.au=Hu%2C+X+W&rft.au=Li%2C+X+R&rft.date=2022-01-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=1177-8881&rft.volume=16&rft.spage=2365&rft_id=info:doi/10.2147%2FDDDT.S371420&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-8881&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-8881&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-8881&client=summon |